Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

491
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
491
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

298
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
298
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

172
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
172
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

648
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
648
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty phenotype transitions and functional improvements during a supervised exercise trial in older people with HIV: results from the HEALTH Trial.

Age and ageing·2026
Same author

Glycemic response trajectories on metformin monotherapy in real-world diabetes care.

medRxiv : the preprint server for health sciences·2026
Same author

Robust ranking of renewable energy alternatives handling uncertainty using novel hesitant bi-fuzzy MEREC-MOORA and Dombi aggregation approach.

Scientific reports·2026
Same author

The Impact of Social Vulnerability on Exercise Outcomes: A Longitudinal Study of Physical Function in Older People With HIV.

Journal of the International Association of Providers of AIDS Care·2026
Same author

Special issue: cell and gene causal inference in the design and analysis of gene therapy clinical trials.

Journal of biopharmaceutical statistics·2026
Same author

Mapping the last mile: Micro-stratification for sustained visceral leishmaniasis elimination in Bangladesh.

PLoS neglected tropical diseases·2026

Related Experiment Video

Updated: Feb 21, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

A modified risk set approach to biomarker evaluation studies.

Debashis Ghosh1

  • 1Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO 80045, U.S.A.

Statistics in Biosciences
|October 10, 2017
PubMed
Summary

This study introduces a new framework using semicompeting risks analysis to evaluate biomarker predictive ability. The predictive hazard ratio is defined and estimated for improved medical decision-making, illustrated with serum albumin in liver disease.

Keywords:
AssociationCausal EffectCopulaCross-ratioDependenceDiagnostics

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

1.2K

Related Experiment Videos

Last Updated: Feb 21, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

1.2K

Area of Science:

  • Biostatistics
  • Medical Decision Making
  • Biomarker Research

Background:

  • Biomarkers are crucial for medical decision-making.
  • Existing methods may not fully capture predictive value in complex clinical scenarios.

Purpose of the Study:

  • To present a simple framework for assessing biomarker predictive ability.
  • To define and discuss the estimation of the predictive hazard ratio.

Main Methods:

  • Utilizes semicompeting risks analysis, a subfield of survival analysis.
  • Modifies the classical risk set approach for medical decision-making.
  • Discusses estimation, inference, and covariate adjustment for the predictive hazard ratio.

Main Results:

  • Defines the predictive hazard ratio, distinct from standard hazard ratios.
  • Illustrates the methodology with serum albumin predicting mortality in primary biliary cirrhosis.

Conclusions:

  • The proposed framework offers a robust method for evaluating biomarker predictive performance.
  • Semicompeting risks analysis provides a valuable tool for medical decision support.